Rchr
J-GLOBAL ID:201401012191966313   Update date: Sep. 08, 2024

Okita Keisuke

オキタ ケイスケ | Okita Keisuke
Affiliation and department:
Research field  (1): Cell biology
Research theme for competitive and other funds  (5):
  • 2019 - 2023 非侵襲的ゲノム・エピゲノム解析による細胞の状態遷移の解明
  • 2012 - 2014 Molecular analysis of immune privilege in pluripotent stem cells
  • 2010 - 2011 Identification of reprogramming inhibitory factors by ES cell differentiation
  • 2007 - 2011 Molecular mechanisms underlying nuclear reprogramming of somatic cells
  • 2006 - 2007 Nanog-GFP細胞を用いた脱分化誘導因子と成体にひそむ多能性細胞の探索
Papers (97):
  • Hasan Al Reza, Zishaan Farooqui, Abid Al Reza, Callen Conroy, Kentaro Iwasawa, Yasuhiro Ogura, Keisuke Okita, Kenji Osafune, Takanori Takebe. Synthetic augmentation of bilirubin metabolism in human pluripotent stem cell-derived liver organoids. Stem Cell Reports. 2023. 18. 11. 2071-2083
  • Ryuichiro Hirayama, Kosuke Toyohara, Kei Watanabe, Takeya Otsuki, Toshikazu Araoka, Shin-Ichi Mae, Tomoko Horinouchi, Tomohiko Yamamura, Keisuke Okita, Akitsu Hotta, et al. iPSC-derived type IV collagen α5-expressing kidney organoids model Alport syndrome. Communications Biology. 2023. 6. 1
  • Kengo Abe, Akihiro Yamashita, Miho Morioka, Nanao Horike, Yoshiaki Takei, Saeko Koyamatsu, Keisuke Okita, Shuichi Matsuda, Noriyuki Tsumaki. Engraftment of allogeneic iPS cell-derived cartilage organoid in a primate model of articular cartilage defect. Nature Communications. 2023. 14. 1
  • Daniel F Kaemena, Masahito Yoshihara, Meryam Beniazza, James Ashmore, Suling Zhao, Mårten Bertenstam, Victor Olariu, Shintaro Katayama, Keisuke Okita, Simon R Tomlinson, et al. B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors. Nature communications. 2023. 14. 1. 488-488
  • Daniel F Kaemena, Masahito Yoshihara, James Ashmore, Meryam Beniazza, Suling Zhao, Marten Bertenstam, Victor Olariu, Shintaro Katayama, Keisuke Okita, Simon Tomlinson, et al. B1 SINE-binding ZFP266 impedes reprogramming through suppression of chromatin opening by pioneering factors. bioRxiv. 2022. 2022.01.04.474927
more...
MISC (226):
Patents (10):
Lectures and oral presentations  (23):
  • Clinical iPSC banking
    (Joint Workshop in Medicine, University of Zurich and Kyoto University 2019)
  • 細胞移植医療へのiPS細胞の活用と問題
    (大学院特別講義、東京医科歯科大学 2019)
  • Application of Japanese homozygous haplotypes in international transplantation
    (ISCBI workshop 2018)
  • Recent situation of clinical application of iPSCs in Japan
    (CRM external seminars, The university of edinburgh 2018)
  • Manufacturing iPS cells for clinical use
    (International Society for Cellular Therapy 22nd Annual Scientific meeting 2016)
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page